Candel Therapeutics, Inc. (CADL) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Candel Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Candel Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $40.5 M, a 39% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $40.5 M +$11.4 M +39% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $29.2 M +$10.7 M +57.7% Dec 31, 2022 10-K 2024-03-28
Q1 2022 $29.2 M Mar 31, 2022 10-K 2023-03-30
Q4 2021 $18.5 M +$7.18 M +63.4% Dec 31, 2021 10-K 2024-03-28
Q4 2020 $11.3 M +$4.23 M +59.7% Dec 31, 2020 10-K 2023-03-30
Q4 2019 $7.09 M Dec 31, 2019 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.